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Introduction
The prevalence of  asthma is highest in ‘developed’ countries 
and lowest in developing and emerging countries. The 
prevalence increases as development progresses (1) and 
is higher in urban compared to rural areas in developing 
countries. This increase may be a result of  several factors 
including:
• The population facing new allergens in an urban 
environment (2).
• A reduced exposure to infectious agents, 
symbiotic micro-organisms and parasites which leads to a 
reduction of  T helper 1 mediated immune responses and 
thus an increase in T helper 2 mediated responses which 
stimulate antibody mediated immunity leading to allergic 
disease. This has been called the ‘hygiene hypothesis’ (3). 
• Increased awareness of  asthma in areas with 
more health provision. 
Even a small rise in asthma prevalence in developing 
countries has important public health implications (4).
This guide should be read together with local guidelines 
including the ‘Prevention and Treatment Guidelines for 
Primary Health Care Centres and Hospitals’ (5). It is not 
meant to replace any of  the recommendations of  local 
guidelines. It is designed to help those managing asthma 
to think about why asthma may be a problem and how to 
overcome that problem. 
Management of asthma - the 5 ‘D’s
I use a simple checklist of  5 ‘D’s (Diagnosis, Drugs, Dose, 
Delivery, Dirty air) when faced with a case of  difficult 
asthma. This checklist explains why the asthma is difficult 
to control. 
Diagnosis
The diagnosis of  asthma is more difficult in developing 
countries with a high prevalence of  tuberculosis and other 
poverty related lung conditions, and HIV associated lung 
diseases. It is likely that many patients with asthma are 
not recognised. Diagnosis in the under 5-year-olds is even 
more difficult due to a high incidence of  viral respiratory 
infections associated with wheeze. I have noted an 
increase in bronchial hyper-reactivity in patients with 
tropical pulmonary eosinophilia in a deprived community 
in India. In the UK I find the following conditions could 
mimic or exacerbate asthma so, rather than add another 
layer of  anti-asthma medication, I always check for:
A for Aspergillus1.  related disease. Both allergic 
bronchopulmonary aspergillosis (ABPA) and 
Severe Asthma with Fungal Sensitisation 
(SAFS) (6) results in asthma which is difficult to 
control. The chest X-ray may show segmental 
or subsegmental collapse, sputum may contain 
Aspergillus fumigatus and blood tests may show 
a raised IgE and raised aspergillus RAST or 
aspergillus precipitins. Anti-fungal treatment 
with intraconazole for one month or more helps 
both conditions. This may be combined with oral 
steroids. 
B for Bronchitis,2.  especially in children where 
viral illness may mimic asthma. There may also be 
a prolonged period of  bronchial hyper-reactivity 
after a respiratory viral illness. 
C for COPD.3.  Chronic obstructive pulmonary 
disease may be difficult to distinguish from asthma. 
The diagnosis is helped by a history of  exposure 
to tobacco smoke or biomass smoke (‘biomass’ is 
biological material from living or recently living 
organisms such as dead branches, wood chippings, 
crop remains) (7). A symptom-based questionnaire 
is available to distinguish COPD from asthma (8)
D for Diffuse lung disease.4.  This can be difficult 
to diagnose without X-ray. Fine crackles, especially 
at the lateral lung bases should alert you to the 
possibility of  an interstitial lung disease such as 
idiopathic pulmonary fibrosis. Spirometry is 
restrictive rather than obstructive. Peak flow may 
be normal. 
E for Embolus.5.  Pulmonary embolus can cause 
rapid onset of  breathlessness and should always 
be considered in patients in whom the degree of  
breathlessness is disproportionate to the severity 
of  their other underlying lung disease or lung 
function.
F for Failure.  6. Heart failure may mimic asthma 
with wheeze and indeed used to be called ‘cardiac 
asthma’. There may be significant reversibility to 
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inhaled beta agonists.  A history of  heart disease 
and the presence of  basal crepitations help to 
make the diagnosis.
G for Gastro-oesophageal reflux (GORD)7.  
which is frequent in asthma patients and may be 
exacerbated by the asthma or be a reason for poor 
asthma control. Always ask whether patients have 
“heart burn” or acid reflux, and treat aggressively. 
Note that use of  anti-acid therapy such as a proton 
pump inhibitor may remove the symptoms of  
acid reflux without stopping the refluxate which 
may still inflame the larynx or airways due to the 
presence of  pepsin (9).
H for Hyperventilation. Hyperventilation8.  is 
frequently associated with asthma and may be 
the cause of  failure of  asthma control. Use of  a 
simple tool such as the Nijmegen Questionnaire 
may help pick up these cases (10).
I for Inhaled foreign body9.  which may cause 
wheeze both in the acute and chronic phase. If  
asthma has been of  rapid onset always ask about 
this possibility. Unilateral wheeze is an important 
sign and indicates the need to try and obtain an 
X-ray. Many foreign bodies however may not 
show on X-ray or CT scan and bronchoscopy is 
required
J for Just never forget local common diseases 10. 
such as tuberculosis which can mimic asthma with 
breathlessness, noisy breathing and cough.
A major problem in diagnosing and treating asthma in 
countries like South Sudan is the lack of  medical equipment. 
Clear history taking is therefore very important. Table 1 
lists important questions to ask to diagnose asthma.
International guidelines for the management of  
asthma usually mention the fundamental need for 
spirometry and blood gases to assess patients and oxygen 
and nebulisers for management. In a questionnaire study 
we undertook of  41 centres in 24 developing countries in 
Africa and Asia (12) we found that continuous electricity 
was available in 25 centres, oxygen in 23 areas, peak 
flow measurement in 26, and spirometry in 3 centres. 
Nebulisers were available in 19 centres and oxygen in 23. 
Peak flow measurement can be a useful and inexpensive 
tool in the diagnosis of  asthma when a 15% improvement 
following administration of  400mcg salbutamol supports 
the diagnosis. Spirometry, particularly using a machine 
which can provide a flow volume loop, is more helpful 
to diagnose COPD and to exclude restrictive lung 
diseases as a cause of  breathlessness. Peak flow meters, 
if  available, can also be used to confirm variation over 
time or show the characteristic morning dip of  asthma. 
We have successfully used colours and symbols on peak 
flow meters to enable home use in an illiterate population 
(see Figures 1a and b.) (13)
Drugs
Always check whether the patient is taking drugs which 
may exacerbate asthma such as beta blockers which may 
be taken orally or as eye drops. 
The problem in developing countries is that the most 
basic drugs required for the management of  asthma 
(such as inhaled bronchodilators and inhaled steroids) are 
unaffordable. In the questionnaire study we undertook 
(12) inhaled steroids were prescribed in only 2 out of  41 
centres. Where they were available, the median (range) 
cost of  a beclomethasone 50 micrograms inhaler was 
20% (6.8-100%) of  average local monthly income and 
a salbutamol inhaler 13% (3.3-250%).  Following the 
publication of  this paper the Asthma Drug Facility (ADF) 
(14) was established by the International Union Against 
Tuberculosis and Lung Disease. Through the ADF, low 
and middle income countries can purchase the quality-
assured asthma medicines they need at affordable cost. 
The ADF has a quality assurance system based on World 
Health Organization norms and standards. It keeps prices 
down by having a competitive process among selected 
manufacturers.  However it is probable that oral medication 
such as oral beta agonists, theophyllines and steroids may 
be the only affordable drugs. For recommendations for the 
management of  acute asthma and maintenance therapy in 
South Sudan see MOH/GOSS 2006 (5).
Dose
The most important aspect of  ‘dose’ is not the 
dose prescribed but the dose that the patient is actually 
Table 1. Important questions to ask to diagnose asthma
From Global Strategy for Asthma Management and        
 Prevention, 2010 Global Initiative for Asthma (11)
Has the patients had an attack or recurrent attacks of  1. 
wheezing?
Does the patient have a troublesome cough at night?2. 
Does the patient wheeze or cough after exercise?3. 
Does the patient experience wheezing, chest tightness 4. 
or cough after exposure to airborne allergens or 
pollutants?
Do the patient’s colds ‘go onto the chest’ or take more 5. 
than 10 days to clear up?
Are symptoms improved by appropriate asthma 6. 
treatment?
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taking. Lack of  funds, fear of  side effects or lack of  
understanding of  the need to take regular medication may 
result in the patient taking a much lower dose of  drug 
than that prescribed, or stopping the medication when the 
symptoms resolve. It is important to:
• Establish the actual dose being taken. 
• Explain the difference in action of  the various 
inhalers, and the fact that the ‘preventer’ steroid inhaler 
should be taken on a regular basis while the ‘reliever’ 
bronchodilator is taken as required. ‘Stepping up’ the dose 
of  inhaled steroids when asthma control is not established 
is frequently considered, but ‘stepping down’ once control 
is established is not so frequently considered. This is 
important as it reduces costs and long term side effects. 
Delivery
The metered dose inhaler (MDI) is the cheapest form 
of  delivery of  asthma medication in most countries and 
therefore the most commonly used and misused (15). 
In my experience the lack of  ability to use the MDI is 
the most common cause of  failure of  asthma control. A 
simple rule is to assume that patients fail to use an MDI 
correctly until proved otherwise . Unfortunately demand 
delivery devices such as dry powder inhalers, or auto 
delivery inhalers are more expensive. The use of  a spacing 
device with an MDI overcomes the problems of  co-
ordination, markedly improves response (16) and reduces 
oropharyngeal side effects of  inhaled steroids. A spacer 
is an additional expense, but a cheap spacer may be made 
from a plastic bottle. It is important to stress the need for 
compliance with the spacer since many patients do not 
feel they are benefitting from their MDI unless they feel 
the spray hitting the back of  the mouth! 
The use of  inhalers should not be a problem for 
Muslims fasting during Ramadan because using a spacer 
device means that most of  the inhaled medication goes 
directly to the lungs and the small amount delivered to the 
oro-pharynx can be rinsed out. 
Dirty Air
The three types of  ‘dirty air’ to consider are inhaled 
smoke, occupational lung disease and allergens. 
• Inhaled tobacco smoke may be passive in 
children and those living with smokers or due to active 
smoking. In the UK many smokers deny smoking, but 
brown discolouration of  the nails, smell of  smoke on 
the breath or, if  necessary, measurement of  end-tidal 
carbon monoxide helps confirm the truth. In developing 
countries smoke inhalation due to the use of  biomass fuels 
in unventilated huts is an important cause of  respiratory 
disease (17). Education and cultural changes may be 
necessary, but these have to adapt to users' needs (18). 
The education level has shown a strong correlation with 
the risk of  respiratory diseases from biomass exposure in 
women; illiterate women are at three to six times higher 
risk for all respiratory diseases compared with literate 
women (19).
• Occupational lung disease. Ask patients with 
asthma about their occupation and whether asthma 
symptoms are better on days they are not working. 
There are many occupational exposures which cause 
or exacerbate asthma and appropriate health and safety 
precautions may not be in place or followed.
Figures 1a and b. Example of  a colour coded peak flow meter and chart for home use by illiterate patients. 
South Sudan Medical Journal                                                                         Vol 5. No 1. February 2012      
SSMJ Vol 5. No 1. February 2012 Downloaded from www.southsudanmedicaljournal.com
mAIN ARTICLES
12
• Allergens may be an important cause of  asthma. 
In 2003 locusts were associated with 11 deaths and 1600 
hospital visits in central Sudan.  Asthma and rhinitis in 
Sudan has also been associated with exposure to airborne 
allergen from the “green nimitti” midge Cladotanytarsus 
lewisi. Urbanisation is associated with an increase in 
exposure to indoor allergens such as the house dust mite 
or pet dander (2), and increased air pollution increases 
sensitisation to allergens.
References
Beasley R, Crane L, Lai CK el al. Prevalence and 1. 
aetiology of  asthma J Allergy Clin Immunol. 2000; 105 (2 
Pt 2): S466-S472
Weinberg EG. Urbanization and childhood asthma: An 2. 
African perspective J Allergy Clin Immunol. 2000; 105: 
224-31
Strachan DP. Family size, infection and atopy: the first 3. 
decade of  the hygiene hypothesis Thorax. 2000;  55 
(Suppl 1): S2-S10
Zar H. 2008 URL http://www.cipp-meeting.org/4. 
proceedings2008/CONTENT/2-SATURDAY_
AFTERNOON/7-KEYNOTE/Heather_Zar.pdf  
(accessed 26 Aug 2011)
MOH/GOSS. Prevention and Treatment Guidelines 5. 
for Primary Health Care Centres and Hospitals, Ministry 
of  Health, Government of  Southern Sudan. 2006. p 
232-235 http://www.southsudanmedicaljournal.com/
assets/files/misc/SS_Treatment_Guidelines07.pdf  
(last accessed 13 Sept 2011)
O’Driscoll BR, Hopkinson LC, Denning DW. Mould 6. 
sensitization is common amongst patients with severe 
asthma requiring multiple hospital admissions. BMC 
Pulm Med. 2005; 5: 4.
Guoping H, Yumin Z, Jia T et al. Risk of  COPD from 7. 
exposure to biomass smoke: a metaanalysis Chest. 2010; 
138(1): 20 - 31. 
Tinkelman DG, Price DB, Nordyke RJ et al. Symptom-8. 
based questionnaire for differentiating COPD and 
asthma Respiration 2006; 73 (3): 296-305
Johnston N, Knight J, Dettmar PW, Lively MO, 9. 
Koufman J. Pepsin and carbonic anhydrase isoenzyme 
III as diagnostic markers for laryngopharyngeal reflux 
disease Laryngoscope. 2004; 114(12): 2129-2134.
van Dixhoorn J, Duivenvoorden HJ. Efficacy of  10. 
Nijmegen Questionnaire in recognition of  the 
hyperventilation syndrome J Psychosom Res. 1985; 29(2): 
199-206
GINA. URL 11. http://www.ginasthma.org/pdf/GINA_
Report_2010.pdf  (accessed 26 Aug 2011)
Watson JP, Lewis RA.  Is asthma treatment affordable 12. 
in developing countries Thorax. 1997; 52: 605-607 
Tenzing C, Lewis RA. Personal  communication13. 
ADF. URL http://www.globaladf.org/ (accessed 26 14. 
Aug 2011)
Crompton GK. Problems patients have using 15. 
pressurized aerosol inhalers.Eur J Respir Dis. 1982; 63: 
(Suppl 119): 101 – 104
Cushley MJ, Lewis RA, Tattersfield AE. Comparison of  16. 
three techniques of  inhalation of  the airway response 
to terbutaline Thorax. 1983; 38: 908-913
Torres-Duque C, Maldonado D, Pérez-Padilla R et al. 17. 
Biomass fuels and respiratory diseases. Proc Am Thor 
Soc. 2008; 5:577 – 590
Budds J, Biran A, Rouse J. 2001.What's cooking? A 18. 
review of  the healthy impacts of  indoor air pollution and 
technical interventions for its reduction. Leicestershire, 
UK: Loughborough University Water, Engineering and 
Development Centre. WELL Task No. 512.
Parikh J, Parikh K, Laxmi Pandey V. Lack of  energy, 19. 
water and sanitation and its impact on rural India. In: 
Parikh K, editor. India Development Report, 2004–
2005: Oxford University Press, p. 84–95.
Conflicts of  interest: none.
I thank Dr Chris Lewis for his comments on the manuscript and for 
supplying Figure 2. Other images are the property of  the author.
Figure 2. Inhalation of  smoke from biomass fuel may cause respiratory 
disease in adults and children.
